Bone Marrow Transplantation Clinical Trials

9 recruitingLast updated: June 18, 2026

There are 9 actively recruiting bone marrow transplantation clinical trials across 4 countries. Studies span Phase 2, Not Applicable. Top locations include Philadelphia, Pennsylvania, United States, Columbus, Ohio, United States, Duarte, California, United States. Updated daily from ClinicalTrials.gov.


Bone Marrow Transplantation Trials at a Glance

9 actively recruiting trials for bone marrow transplantation are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Philadelphia, Columbus, and Duarte. Lead sponsors running bone marrow transplantation studies include Investigator driven study, Jennifer Jones, and Institute of Hematology & Blood Diseases Hospital, China.

Browse bone marrow transplantation trials by phase

Treatments under study

About Bone Marrow Transplantation Clinical Trials

Looking for clinical trials for Bone Marrow Transplantation? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bone Marrow Transplantation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bone Marrow Transplantation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors

Graft-Versus-Host-Disease (GVHD)Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine82 enrolled1 locationNCT07570745
Recruiting
Phase 2

MAGIC Ruxolitinib for aGVHD

Acute Graft Versus Host Diseaseadverse effectsAllogeneic Bone Marrow Transplantation
John Levine98 enrolled14 locationsNCT06936566
Recruiting
Not Applicable

Rehab Study for alloBMT Patients

Allogenic Bone Marrow Transplantation
Jennifer Jones208 enrolled1 locationNCT07457866
Recruiting
Phase 2

Orphan Indications for CD19 Redirected Autologous T Cells

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALLPatients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation
Stephan Grupp MD PhD133 enrolled1 locationNCT04276870
Recruiting

National Longitudinal Cohort of Hematological Diseases

Acute Myeloid LeukemiaMultiple MyelomaMyelodysplastic Syndrome+14 more
Institute of Hematology & Blood Diseases Hospital, China2,300 enrolled1 locationNCT04645199
Recruiting

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

Multiple MyelomaMyelodysplastic SyndromeLymphoma+12 more
Yigeng Cao,MD,PhD1,000 enrolled1 locationNCT07205523
Recruiting

Biomarkers in Transplant Recipients to Improve Outcomes

Bone Marrow TransplantationSolid-organ Transplantation
University of Pittsburgh1,200 enrolled1 locationNCT01163578
Recruiting
Not Applicable

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC)

NeoplasmsBone Marrow Transplantation
Murdoch Childrens Research Institute880 enrolled4 locationsNCT05667766
Recruiting

The immunogenicity of 7-valent pneumococcal conjugate vaccine (PCV-7) in allogeneic bone marrow transplant recipients

Patient is scheduled to have allogeneic bone marrow transplantation (mathced realted or unrealted) excluding cord transplant.
Investigator driven study30 enrolled1 locationACTRN12605000773639